Schizophrenia, depression, biopolar disorder share ‘overlapping’ mutations

Types of bipolar disorder
Image credit: Mental Health Area

Is lower academic achievement in early life tied to the same gene changes as an increased risk for Alzheimer’s in older age? That is one of dozens of possible deductions to be drawn from the largest genomic study of brain conditions ever conducted, research that obscures what often have been considered clear diagnostic borders.

According to the findings, published June 22 in Science, conditions such as schizophrenia, major depressive disorder (MDD) and bipolar disorder share a suite of overlapping genetic variants rather than having distinct genetic signatures.

In addition to the genetic links between educational attainment and Alzheimer’s risk, the results link neuroticism to anorexia nervosa, anxiety disorders, MDD and obsessive-compulsive disorder (OCD). Neurological disorders like Parkinson’s and multiple sclerosis, however, have few variants in common with each other or with psychiatric conditions.

“One of the big messages is that psychiatric disorders turned out to be very connected on the genetic level,” says Verneri Anttila, the first author on the paper.

With dozens of new investigative starting points involving these common variants in-hand, what’s next? “The immediate takeaway from this study is that now that we have identified these connections, we can better understand how these disorders arise,” says Anttila. “There may be some deeper genetic mechanisms at play here [that] predispose individuals to multiple disorders, rather than just a single one.”

Read full, original post: Analysis of a Million-Plus Genomes Points to Blurring Lines among Brain Disorders

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
Screenshot 2026-05-08 at 3.01
Transforming farming and nutrition with AI and robotics? Larry Ellison’s half-billion-dollar Hawaii greenhouse dream goes bust
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
ChatGPT-Image-May-8-2026-01_41_33-PM-3
Viewpoint: Surge of climate misinformation traced to right wing and anti-wind activists 
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.